Zobrazeno 1 - 10
of 143
pro vyhledávání: '"S. FOSSI"'
Publikováno v:
Sciences, Eaux & Territoires, Iss Articles hors-série 2014 (2014)
La Guinée prévoit de construire dans le bassin du Niger, le barrage de Fomi. Ce barrage en remblais de 42 m de hauteur, créera une retenue de 507 km² et d'un volume d'environ 6,2 milliards de m3. Cette étude s'intéresse à la capacité des pér
Externí odkaz:
https://doaj.org/article/e3d01055fe294721a2fe19c25ad3c931
Autor:
S. Fossi, Antonello Grippo, Francesco Pinto, M C Campolo, Riccardo Carrai, Aldo Amantini, Giovanni Lanzo
Publikováno v:
Neurophysiologie Clinique/Clinical Neurophysiology. 39:95-100
Summary Introduction Post-traumatic locked-in syndrome may be particularly difficult to recognize, especially when it follows a state of coma and presents the clinical feature of a “total” locked-in syndrome. Patient and methods A 56-year-old mal
Publikováno v:
AMBIO: A Journal of the Human Environment. 36:308-315
The main aims of the present study, conducted in the framework of the MONIQUA-Egadi Scientific Project, were twofold: first, to make the first step in the development and validation of an ecotoxicological approach for the assessment of marine polluti
Autor:
L. Bucciardini, S. Scarpelli, A. Amadori, C. Cossu, Antonello Grippo, R. Sgalla, S. Fossi, Francesco Pinto, Aldo Amantini, I. Bruni, P. Innocenti
Publikováno v:
Neurophysiologie Clinique/Clinical Neurophysiology. 36:195-205
Aims To evaluate the feasibility of a continuous neurophysiologic monitoring (electroencephalography (EEG)–somatosensory evoked potentials (SEPs)) in the neuro-intensive care unit (NICU), taking into account both the technical and medical aspects t
Publikováno v:
Neurological Sciences. 24:397-400
The prognostic significance of post-anoxic-ischemic alpha coma (AC) is controversial. We recorded somatosensory evoked potentials (SEPs) and performed serial electroencephalography (EEG) in a 60-year-old woman in coma after cardiac arrest. The first
Autor:
Enrico Roda, D. Panuccio, S. Fossi, Paolo Pozzato, Franco Bazzoli, Giovanna Masala, Rocco Maurizio Zagari, G. Nicolini, Domenico Palli, Davide Festi, Luigi Ricciardiello
Publikováno v:
Alimentary Pharmacology & Therapeutics. 15:1001-1007
Objectives: As part of a cross-sectional study on cholelithiasis, 1533 out of 1840 residents in Loiano/Monghidoro, a rural area in Northern Italy (792 men, 741 women, age range 28–80 years), agreed to be further evaluated in relation to their Helic
Autor:
S. Fossi, Luigi Ricciardiello, B. Gorini, S. Maltoni, C. Martuzzi, Franco Bazzoli, G. Nicolini, Paolo Pozzato, Lorenzo Fuccio, Debora Berretti, L. De Luca, Enrico Roda, Rocco Maurizio Zagari
Publikováno v:
Journal of Chemotherapy. 11:601-605
The fact that about 50% of the world's population is infected with Helicobacter (H.) pylori and the important role that this bacterium plays in public health have been important incentives in the search for accurate diagnostic methods. A large number
Autor:
Enrico Roda, Francesco Piazza, Franco Bazzoli, Laura Zambonin, Mario Baraldini, S. Fossi, Patrizia Pasini, Aldo Roda
Publikováno v:
Analytical Biochemistry. 264:47-52
A chemiluminescent urease activity assay has been developed and optimized using the chemiluminescent pH indicator phthalhydrazidylazoacetylacetone. This compound is stable at pH
Autor:
S. Fossi, Franco Bazzoli, G. Nicolini, Debora Berretti, M. Zagari, Luigi Ricciardiello, Luca De Luca, Paolo Pozzato
Publikováno v:
Helicobacter. 3:195-201
Background. The combination of lansoprazole with antibiotics either as double or triple therapy has demonstrated an H. pylori eradication rate of between 80 and 90%. With the aim of providing a complete revision of the results of these clinical studi
Autor:
Paolo Pozzato, S. Fossi, Cannizzaro O, Ederle A, G. Iaquinto, A. Olivieri, Franco Bazzoli, Gerace G, D'Angelo A, Reina G, Scarpulla G, R. Tosatto, Spadaccini A, Luigi Ricciardiello, Enrico Roda, M. Zagari
Publikováno v:
Alimentary Pharmacology & Therapeutics. 12:533-537
Background: This multicentre, randomized study was designed to assess the clinical efficacy, safety and tolerability of three novel 7-day triple therapies containing ranitidine bismuth citrate (RBC) and two antibiotics. Methods: We studied patients w